Vivani Medical (VANI) Short term Debt (2020 - 2021)
Vivani Medical (VANI) posted quarterly Short term Debt of $2.2 million for Q1 2021, little changed quarter-over-quarter from $2.2 million in Q4 2020.
Vivani Medical (VANI) Short term Debt (2020 - 2021) Analysis & Trends
Vivani Medical's Short term Debt history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2021.
- In Q1 2021, Short term Debt changed N/A year-over-year to $2.2 million; the TTM figure through Mar 2021 stood at $2.2 million (changed N/A YoY), while the FY2020 annual figure was $2.2 million, changed N/A from the prior year.
- Short term Debt for Q1 2021 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
- The five-year high for Short term Debt was $2.2 million in Q4 2020, with the low at $2.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 2.20 Mn |